Haleon (NYSE: HLN) CFO receives performance shares, sells portion for tax
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Haleon plc reported that Chief Financial Officer Dawn Allen received a vesting of performance-based share awards under the Haleon Performance Share Plan. On 30 June 2026, she acquired 283,193.151771 ordinary shares at nil cost, reflecting achievement of performance conditions through 31 December 2025 and continued employment requirements.
As part of the same event, 133,300.732432 shares were automatically sold on the London Stock Exchange at £3.523867 per share to meet tax liabilities. The remaining shares are subject to Haleon’s shareholding requirements, as well as malus and clawback provisions designed to align executive rewards with long-term performance.
Positive
- None.
Negative
- None.
Key Figures
Performance shares vested: 283,193.151771 shares
Shares sold for tax: 133,300.732432 shares
Tax sale price: £3.523867 per share
+1 more
4 metrics
Performance shares vested
283,193.151771 shares
Award vesting to CFO on 30 June 2026 at nil price
Shares sold for tax
133,300.732432 shares
Automatic disposal to cover tax liabilities on 30 June 2026
Tax sale price
£3.523867 per share
Price for automatic disposal on London Stock Exchange (XLON)
Transaction date
30 June 2026
Date of acquisition and automatic disposal transactions
Key Terms
Performance Share Plan, malus and clawback, Market Abuse Regulation, Person Discharging Managerial Responsibilities (PDMR), +1 more
5 terms
malus and clawback financial
"The award is subject to malus and clawback provisions."
Malus and clawback are rules that let a company reduce or recover pay previously promised or already paid to executives or insiders when performance, misconduct, or accounting problems occur. Think of malus as withholding future bonuses before they are paid and clawback as reclaiming money already given, like a landlord keeping or returning part of a security deposit; investors care because these protections help align management incentives with long-term company health and can limit financial and reputational risk.
Market Abuse Regulation regulatory
"notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation"
Market abuse regulation consists of laws and rules designed to prevent dishonest or manipulative practices in financial markets. It aims to ensure fair and transparent trading, so investors can trust that markets operate honestly, much like rules that keep a game fair. By reducing unfair advantages, it helps protect investor confidence and promotes healthy, efficient markets.
Person Discharging Managerial Responsibilities (PDMR) regulatory
"Transactions by a Person Discharging Managerial Responsibilities ("PDMR")."
A person discharging managerial responsibilities (PDMR) is a senior executive or board-level individual who regularly has access to confidential, price‑sensitive information about a company. For investors, identifying PDMRs matters because their stock trades must be reported and are closely watched as potential signals of insider knowledge or leadership confidence — like watching team captains’ moves to gauge the team’s prospects.
automatic disposal financial
"Automatic disposal of Ordinary Shares resulting from Haleon plc Performance Share Plan (Buyout Award) vesting to cover tax liabilities."
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2026
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
|
|
Form
20-F ☒
|
Form
40-F ☐
|
|
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
99.1
|
02 July
2026 - “Director/PDMR
Shareholding”
|
99.1
Haleon plc: Director/PDMR
Shareholding
2 July 2026: Haleon
plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces
notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by a
Person Discharging Managerial Responsibilities
("PDMR").
This notification sets out the details of the vesting of a Haleon
share award over ordinary shares made to a PDMR in October 2024
under the Haleon Performance Share Plan and the subsequent sale of
ordinary shares to meet tax liabilities.
On 30 June 2026, Dawn Allen, Chief Financial Officer, received the
vesting of an award of Haleon ordinary shares under the Haleon
Performance Share Plan. Vesting included dividends
accrued.
The award under the Performance Share Plan was conditional on
continued employment and on the satisfaction of the performance
conditions over the performance period ended on 31 December 2025
approved by the Remuneration Committee, which (after tax on the
gross award) must be retained until the shareholding requirement is
met, and in any event for Executive Directors two years after
receipt.
Performance targets and levels of achievement are disclosed in the
2025 Annual Report and 20-F. The award is subject to malus and clawback
provisions.
|
1
|
Details of the issuer or emission allowance market
participant
|
||
|
a)
|
Name of the entity
|
Haleon plc
|
|
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
|
|
2
|
Reason for the notification
|
||
|
a)
|
Position/status
|
Chief Financial Officer
|
|
|
b)
|
Initial notification /Amendment to prior
notifications
|
Initial Notification
|
|
|
3
|
Details of the person discharging managerial responsibilities /
person closely associated ("PCA")
|
||
|
a)
|
PDMR/PCA
|
PDMR
|
|
|
b)
|
Name
|
Dawn Allen
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of Instrument
|
Share
|
|
|
|
|
||
|
Identification code
|
GB00BMX86B70
|
||
|
|
|
||
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares in respect of the Haleon plc
Performance Share Plan (Buyout award).
|
|
|
c)
|
Currency, Price(s) and Volume(s)
|
Price(s)
|
Volume(s)
|
|
|
|||
|
|
Nil
|
283,193.151771
|
|
|
|
|||
|
d)
|
Aggregated information
|
|
|
|
|
|
||
|
- Aggregated volume
|
N/A
|
||
|
|
|
||
|
- Price
|
|
||
|
|
|
||
|
e)
|
Date of the transaction
|
30 June 2026
|
|
|
f)
|
Place of the transaction
|
Outside a trading venue
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of Instrument
|
Share
|
|
|
|
|
||
|
Identification code
|
GB00BMX86B70
|
||
|
|
|
||
|
b)
|
Nature of the transaction
|
Automatic disposal of Ordinary Shares resulting from Haleon plc
Performance Share Plan (Buyout Award) vesting to cover tax
liabilities.
|
|
|
c)
|
Currency, Price(s) and Volume(s)
|
Price(s)
|
Volume(s)
|
|
|
|||
|
|
£3.523867
|
133,300.732432
|
|
|
|
|||
|
d)
|
Aggregated information
|
|
|
|
|
|
||
|
- Aggregated volume
|
N/A
|
||
|
|
|
||
|
- Price
|
|
||
|
|
|
||
|
e)
|
Date of the transaction
|
30 June 2026
|
|
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused
on better everyday health. Our people, our brands, our research,
our investment and our innovation are aimed at improving the
everyday health of consumers. Our product portfolio spans six major
categories - Oral Health, Vitamins, Minerals and Supplements (VMS),
Pain Relief, Respiratory Health, Digestive Health and Therapeutic
Skin Health and Other. Our superior brands - such
as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are trusted by more than one billion
consumers and are recommended by health professionals around the
world.
For more information, please visit www.haleon.com.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
HALEON PLC
(Registrant)
|
|
|
Date:
July 02, 2026
|
By:
|
/s/
Amanda Mellor
|
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|